University of Edinburgh Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Leeds Featured PhD Programmes

radiotherapy PhD Projects, Programs & Scholarships

We have 42 radiotherapy PhD Projects, Programs & Scholarships

  • "radiotherapy" ×
  • clear all
Order by 
Showing 11 to 20 of 42
  HDAC inhibitors: a potential therapy for breast cancer?
  Dr C Staton, Dr B Corfe
Applications accepted all year round

Funding Type

PhD Type

Radiation resistance, due to hypoxia, remains a major cause of mortality in the treatment of breast cancer.
  Harnessing the cancer-specific immune response to radiotherapy
  Prof A Gallimore
Application Deadline: 25 November 2019

Funding Type

PhD Type

The ‘GW4 BioMed MRC DTP’ is awarding up to 18 studentships with an October 2020 start date, aligned with the themes of Infection, Immunity and Repair; Neuroscience and Mental Health; and Population Health.
  (MCRC Non-Clinical) Exploiting ERK5-signalling to modify T-cell behaviour during tumour progression and radiotherapy response: a new immunotherapy approach?
  Dr K Finegan, Dr J Honeychurch, Prof K Williams, Prof T Illidge
Application Deadline: 1 December 2019

Funding Type

PhD Type

Project summary. ERK5 is a signalling protein that enables cells to transduce extracellular signals into responses. It is expressed in all tissues and is up-regulated in tumours.
  MRC DiMeN Doctoral Training Partnership: Activation of Aurora Kinase A by DNA damage – understanding the signalling pathway to improve radiotherapy response
  Dr H Bryant, Prof C Eyers, Prof P Eyers
Application Deadline: 6 January 2020

Funding Type

PhD Type

Radiation is a mainstay of cancer therapy, however radioresistance is a significant challenge in the treatment of locally advanced, recurrent and metastatic cancers.
  Peptide hydrogels as novel nanotherapeutic delivery agents enhancing the anti-tumour efficacy of radiotherapy
  Dr J Coulter, Dr G Laverty
Applications accepted all year round

Funding Type

PhD Type

There is a pressing clinical need for effective localised cancer treatments. Addressing this need we will develop a novel drug delivery system comprised of a nanoparticle/drug releasing hydrogel implant.
  Radiation induced oxidative DNA damage and cancer immunology in NSCLC
  Dr C Hiley, Dr S Boulton
Application Deadline: 29 November 2019

Funding Type

PhD Type

Forty percent of all patients cured of cancer have radiotherapy as part of their treatment. Lung cancer is the most common cause of cancer death in the UK and in non-small cell lung cancer (NSCLC) radiotherapy is the standard of care for patients with stage III disease.
  Pre-clinical investigations of POLQ inhibitors
  Dr G Higgins, Prof T Humphrey
Application Deadline: 10 January 2020

Funding Type

PhD Type

THE PROJECT. The aim of our research is to improve radiotherapy for cancer patients by making tumour cells more sensitive to radiation without affecting the sensitivity of normal cells.
  Ubiquitin signalling in the pathogenesis and therapy of glioblastoma
  Dr V D'Angiolella, Prof A Ryan
Application Deadline: 4 December 2019

Funding Type

PhD Type

THE PROJECT. Glioblastoma, the most common primary brain tumor in adults accounts for more than 4000 deaths every year in the UK.
  (MCRC Non-Clinical) Assessing the impact of oxygen tension on the generation of cancer immunity
  Prof J O'Connor, Dr J Honeychurch, Prof K Williams
Application Deadline: 1 December 2019

Funding Type

PhD Type

Project summary. The importance of T-cell immunity to cancer outcome is becoming increasingly well-recognised.
  Understanding and minimizing radiation damage in breast tissues
  Dr M Sherratt, Miss C Kirwan, Prof S Cartmell
Applications accepted all year round

Funding Type

PhD Type

Human beings are subjected to many forms of radiation both natural (principally ultraviolet radiation [UVR]) and artificial (diagnostic and therapeutic X-rays).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.